S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Sell every Stock except ONE (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
Sell every Stock except ONE (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Laser breakthrough could send stock soaring 2,467% (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Sell every Stock except ONE (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
Sell every Stock except ONE (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Laser breakthrough could send stock soaring 2,467% (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Sell every Stock except ONE (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
Sell every Stock except ONE (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Laser breakthrough could send stock soaring 2,467% (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Sell every Stock except ONE (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
Sell every Stock except ONE (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Laser breakthrough could send stock soaring 2,467% (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain

Coronavirus Therapeutics Stocks List

Compare coronavirus therapeutics stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$223.42
-0.4%
$238.95
$220.44
$296.67
$119.38 B0.642.34 million shs2.40 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$78.85
+0.8%
$81.12
$57.17
$89.74
$98.35 B0.385.85 million shs5.69 million shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$759.05
+1.5%
$788.76
$538.01
$837.55
$82.98 B0.23552,505 shs555,800 shs
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
$0.31
-20.3%
$0.31
$0.16
$3.09
$145.01 M1.9552.69 million shs176.99 million shs
AbbVie Inc. stock logo
ABBV
AbbVie
$145.11
+1.2%
$155.14
$134.09
$168.11
$256.02 B0.585.89 million shs5.61 million shs
GSK plc stock logo
GSK
GSK
$35.61
+1.1%
$36.12
$28.47
$45.14
$72.91 B0.673.38 million shs2.64 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$442.38
+1.0%
$378.15
$283.11
$447.51
$419.94 B0.373.18 million shs3.44 million shs

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
0.00%-4.09%-8.38%-7.11%-9.73%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.00%+0.86%-8.92%-6.98%+23.50%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.00%+1.97%-5.21%+1.38%+14.81%
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
0.00%+55.17%-6.39%+1.61%-80.19%
AbbVie Inc. stock logo
ABBV
AbbVie
0.00%-1.39%-10.65%-4.10%-3.91%
GSK plc stock logo
GSK
GSK
0.00%-2.52%-3.00%-0.75%-20.01%
Eli Lilly and Company stock logo
LLY
Eli Lilly and
0.00%+1.83%+14.83%+34.71%+48.03%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amgen Inc. stock logo
AMGN
Amgen
2.6661 of 5 stars
2.14.05.03.92.11.71.9
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
3.1002 of 5 stars
2.33.04.24.12.92.53.8
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.68 of 5 stars
3.44.00.03.72.72.51.9
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
1.8404 of 5 stars
3.30.00.04.41.10.00.6
AbbVie Inc. stock logo
ABBV
AbbVie
2.708 of 5 stars
2.23.04.23.93.12.51.9
GSK plc stock logo
GSK
GSK
2.2083 of 5 stars
0.03.03.30.03.20.01.9
Eli Lilly and Company stock logo
LLY
Eli Lilly and
3.0581 of 5 stars
2.45.03.34.02.42.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.15
Hold$250.9412.32% Upside
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.53
Moderate Buy$91.0015.41% Upside
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.75
Moderate Buy$850.2112.01% Upside
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
2.50
Moderate Buy$9.002,828.73% Upside
AbbVie Inc. stock logo
ABBV
AbbVie
2.43
Hold$163.4012.60% Upside
GSK plc stock logo
GSK
GSK
2.09
Hold$1,576.884,328.18% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and
2.71
Moderate Buy$415.75-6.02% Downside

Current Analyst Ratings

Latest Coronavirus Therapeutics Stocks Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/16/2023
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$90.00 ➝ $100.00
5/15/2023
Eli Lilly and Company stock logo
LLY
Eli Lilly and
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$478.00 ➝ $507.00
5/8/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$960.00 ➝ $935.00
5/5/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMaintains
5/5/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$880.00 ➝ $927.00
5/5/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$976.00 ➝ $895.00
5/4/2023
Eli Lilly and Company stock logo
LLY
Eli Lilly and
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$430.00 ➝ $505.00
5/4/2023
Eli Lilly and Company stock logo
LLY
Eli Lilly and
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$430.00 ➝ $475.00
5/4/2023
Eli Lilly and Company stock logo
LLY
Eli Lilly and
Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$420.00 ➝ $490.00
5/3/2023
Amgen Inc. stock logo
AMGN
Amgen
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$208.00 ➝ $214.00
5/3/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$856.00 ➝ $1,050.00
(Data available from 5/22/2020 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$26.32B4.54$24.26 per share9.21$10.01 per share22.32
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$27.28B3.61$9.05 per share8.71$16.79 per share4.70
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$12.17B6.82$45.21 per share16.79$214.91 per share3.53
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
$60.32M2.40N/AN/A$0.26 per share1.18
AbbVie Inc. stock logo
ABBV
AbbVie
$58.05B4.41$18.92 per share7.67$7.54 per share19.25
GSK plc stock logo
GSK
GSK
$36.28B2.01$4.51 per share7.89$6.71 per share5.31
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$28.54B14.71$9.26 per share47.78$11.90 per share37.17

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$6.55B$14.7115.1911.601.7730.23%248.47%13.54%8/3/2023 (Estimated)
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$4.59B$4.4317.8010.860.9020.65%39.35%13.11%8/1/2023 (Estimated)
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$4.34B$36.8020.6320.822.3933.81%20.41%15.79%8/2/2023 (Estimated)
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
-$428.33MN/A0.00N/AN/A-818.22%-282.82%-57.64%N/A
AbbVie Inc. stock logo
ABBV
AbbVie
$11.84B$4.2334.3013.162.6113.37%153.92%16.91%8/4/2023 (Estimated)
GSK plc stock logo
GSK
GSK
$18.50B$8.284.309.271.7647.85%43.27%8.55%7/26/2023 (Confirmed)
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$6.24B$6.2970.3337.112.3320.54%61.42%12.74%8/3/2023 (Estimated)

Latest Coronavirus Therapeutics Stocks Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/26/2023N/A
GSK plc stock logo
GSK
GSK
$0.84N/A-$0.84N/AN/AN/A
4/27/2023Q1 2023
Amgen Inc. stock logo
AMGN
Amgen
$3.84$3.98+$0.14$2.68$6.18 billion$6.11 billion    
4/27/2023Q1 2023
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.63$1.37-$0.26$1.94$6.33 billion$6.35 billion    
4/27/2023Q1 2023
AbbVie Inc. stock logo
ABBV
AbbVie
$2.44$2.46+$0.02$4.79$12.23 billion$12.23 billion    
4/27/2023Q1 23
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$1.73$1.62-$0.11$1.75$6.87 billion$6.96 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$8.523.81%+10.14%57.92%11 Years
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.003.80%+5.03%67.72%8 Years
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
N/AN/AN/AN/AN/A
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
N/AN/AN/AN/AN/A
AbbVie Inc. stock logo
ABBV
AbbVie
$5.924.08%+9.16%139.95%51 Years
GSK plc stock logo
GSK
GSK
$1.363.82%N/A16.43%N/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and
$4.521.02%+15.02%71.86%9 Years

Latest Coronavirus Therapeutics Stocks Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/26/2023
GSK plc stock logo
GSK
GSK
quarterly$0.34755.6%5/18/20235/19/20237/13/2023
4/25/2023
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Quarterly$0.753.65%6/14/20236/15/20236/29/2023
5/1/2023
Eli Lilly and Company stock logo
LLY
Eli Lilly and
quarterly$1.131.11%5/12/20235/15/20236/9/2023
3/7/2023
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.133.73%5/17/20235/18/20236/8/2023
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
11.36
3.14
2.79
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1.10
1.28
1.13
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.11
5.45
4.67
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
0.14
0.88
0.79
AbbVie Inc. stock logo
ABBV
AbbVie
4.46
0.96
0.82
GSK plc stock logo
GSK
GSK
1.47
0.95
0.69
Eli Lilly and Company stock logo
LLY
Eli Lilly and
1.67
1.30
1.02

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
75.53%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
78.72%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
84.25%
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
34.48%
AbbVie Inc. stock logo
ABBV
AbbVie
67.71%
GSK plc stock logo
GSK
GSK
13.15%
Eli Lilly and Company stock logo
LLY
Eli Lilly and
82.13%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.46%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.16%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8.83%
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
2.60%
AbbVie Inc. stock logo
ABBV
AbbVie
0.26%
GSK plc stock logo
GSK
GSK
10.00%
Eli Lilly and Company stock logo
LLY
Eli Lilly and
0.13%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
25,200534.33 million531.87 millionOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,0001.25 billion1.25 billionOptionable
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
11,851109.33 million99.67 millionOptionable
Sorrento Therapeutics, Inc. stock logo
SRNE
Sorrento Therapeutics
799471.88 million459.61 millionOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.76 billion1.76 billionOptionable
GSK plc stock logo
GSK
GSK
69,4002.05 billion1.84 billionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and
39,000949.27 million948.04 millionOptionable

Coronavirus Therapeutics Stocks Headlines

SourceHeadline
Eli Lil­ly high­lights pow­er of fu­ture mem­o­ries in lat­est Verzenio ad for metasta­t­ic breast can­cerEli Lil­ly high­lights pow­er of 'fu­ture mem­o­ries' in lat­est Verzenio ad for metasta­t­ic breast can­cer
endpts.com - May 19 at 5:10 PM
PNC Financial Services Group Inc. Sells 3,979 Shares of Eli Lilly and Company (NYSE:LLY)PNC Financial Services Group Inc. Sells 3,979 Shares of Eli Lilly and Company (NYSE:LLY)
marketbeat.com - May 19 at 2:00 PM
Eli Lilly Overtakes Rival, Becomes World’s Most Valuable Pharma CompanyEli Lilly Overtakes Rival, Becomes World’s Most Valuable Pharma Company
wibc.com - May 18 at 11:31 PM
Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market (LLY)Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market (LLY)
marketbeat.com - May 18 at 8:44 AM
Scribe and Prevail ink $75m CRISPR dealScribe and Prevail ink $75m CRISPR deal
bioprocessintl.com - May 18 at 8:29 AM
Lillys rheumatoid arthritis drug peresolimab shows promise in mid-stage studyLilly's rheumatoid arthritis drug peresolimab shows promise in mid-stage study
msn.com - May 18 at 8:29 AM
Is Eli Lilly and Company (LLY) an Attractive Growth Stock?Is Eli Lilly and Company (LLY) an Attractive Growth Stock?
finance.yahoo.com - May 18 at 8:29 AM
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential (LLY)Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential (LLY)
marketbeat.com - May 18 at 7:08 AM
Eli Lilly and Company (NYSE:LLY) CAO Donald A. Zakrowski Sells 600 SharesEli Lilly and Company (NYSE:LLY) CAO Donald A. Zakrowski Sells 600 Shares
americanbankingnews.com - May 18 at 6:04 AM
Lilly Endowment Inc Sells 20,646 Shares of Eli Lilly and Company (NYSE:LLY) StockLilly Endowment Inc Sells 20,646 Shares of Eli Lilly and Company (NYSE:LLY) Stock
americanbankingnews.com - May 18 at 4:40 AM
Eli Lilly becomes world’s most valuable pharma companyEli Lilly becomes world’s most valuable pharma company
953mnc.com - May 17 at 8:23 PM
Billionaire Investor Stanley Druckenmiller Warns Of Biggest And Probably Broadest Asset Bubble — Heres How Hes Preparing For The Grand FinaleBillionaire Investor Stanley Druckenmiller Warns Of 'Biggest And Probably Broadest Asset Bubble' — Here's How He's Preparing For 'The Grand Finale'
benzinga.com - May 17 at 3:23 PM
Lilly overtakes rival J&J in market cap to become world’s most valuable drugmakerLilly overtakes rival J&J in market cap to become world’s most valuable drugmaker
ibj.com - May 17 at 3:23 PM
Eli Lilly and Company (NYSE:LLY) Receives $412.80 Average Target Price from BrokeragesEli Lilly and Company (NYSE:LLY) Receives $412.80 Average Target Price from Brokerages
americanbankingnews.com - May 17 at 4:19 AM
Eli Lilly and (NYSE:LLY) PT Raised to $507.00 at Morgan StanleyEli Lilly and (NYSE:LLY) PT Raised to $507.00 at Morgan Stanley
americanbankingnews.com - May 17 at 2:54 AM
Scribe Announces Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Accelerate In Vivo CRISPR-based Genetic Medicines for Neurological and Neuromuscular DiseasesScribe Announces Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Accelerate In Vivo CRISPR-based Genetic Medicines for Neurological and Neuromuscular Diseases
businesswire.com - May 16 at 7:46 PM
Eli Lilly Is a Winning Bet for Its Weight Loss DrugEli Lilly Is a Winning Bet for Its Weight Loss Drug
barrons.com - May 16 at 2:45 PM
With 84% ownership of the shares, Eli Lilly and Company (NYSE:LLY) is heavily dominated by institutional ownersWith 84% ownership of the shares, Eli Lilly and Company (NYSE:LLY) is heavily dominated by institutional owners
finance.yahoo.com - May 16 at 2:45 PM
Eli Lilly Stock Doesnt Have To Shoot Higher For ProfitsEli Lilly Stock Doesn't Have To Shoot Higher For Profits
finance.yahoo.com - May 16 at 2:45 PM
The Turnaround for Weight Watchers is Taking Shape (LLY)The Turnaround for Weight Watchers is Taking Shape (LLY)
marketbeat.com - May 16 at 7:04 AM
What 20 Analyst Ratings Have To Say About Eli LillyWhat 20 Analyst Ratings Have To Say About Eli Lilly
markets.businessinsider.com - May 15 at 4:40 PM
What are some of the key takeaways from Eli Lillys Alzheimers drug trial?What are some of the key takeaways from Eli Lilly's Alzheimer's drug trial?
richmond.com - May 15 at 9:32 AM
The Peoples Pharmacy: What are key takeaways from Eli Lillys Alzheimers drug trial?The People's Pharmacy: What are key takeaways from Eli Lilly's Alzheimer's drug trial?
richmond.com - May 14 at 2:35 PM
Eli Lilly and Company (LLY) Presents at Bank of America Securities 2023 Healthcare ConferenceEli Lilly and Company (LLY) Presents at Bank of America Securities 2023 Healthcare Conference
seekingalpha.com - May 14 at 11:05 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Amgen logo

Amgen

NASDAQ:AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Gilead Sciences logo

Gilead Sciences

NASDAQ:GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals

NASDAQ:REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Sorrento Therapeutics logo

Sorrento Therapeutics

NASDAQ:SRNE
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. It operates through the Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
AbbVie logo

AbbVie

NYSE:ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
GSK logo

GSK

NYSE:GSK
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations, Research and Development, and Consumer Healthcare. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Eli Lilly and logo

Eli Lilly and

NYSE:LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

My Account -